Abstract: A micro light emitting device includes an epitaxial structure, a conductive layer, and a first insulating layer. The epitaxial structure has a first surface and a second surface opposite to the first surface, and includes a first semiconductor layer, an active layer and a second semiconductor layer that are arranged in such order in a direction from the first surface to the second surface. The conductive layer is formed on a surface of the first semiconductor layer away from the active layer. The first insulating layer is formed on the surface of the first semiconductor layer away from the active layer, and exposes at least a part of the conductive layer.

Abstract: A polymer composition comprises a polypropylene polymer and a salt of a branched alkyl phosphonic acid.

Abstract: A semiconductor structure includes a first gate structure, a second gate structure coupled to the first gate structure, a source region, a first drain region, and a second drain region. The source region is surrounded by the first gate structure and the second gate structure. The first drain region is separated from the source region by the first gate structure. The second drain region is separated from the source region by the second gat structure. A shape of the first drain region and a shape of the second drain region are different from each other from a plan view.

Abstract: A manufacturing method of a semiconductor device includes at least the following steps. A sacrificial substrate is provided. An epitaxial layer is formed on the sacrificial substrate. An etch stop layer is formed on the epitaxial layer. Carbon atoms are implanted into the etch stop layer. A capping layer and a device layer are formed on the etch stop layer. A handle substrate is bonded to the device layer. The sacrificial substrate, the epitaxial layer, and the etch stop layer having the carbon atoms are removed from the handle substrate.

Abstract: An composition comprises a first component and one or more calcium cis-1,2-cyclohexanedicarboxylate salts. The first component is selected from thermoplastic polymers, waxes, and mixtures thereof. 25 mol. % or more of the calcium cis-1,2-cyclohexanedicarboxylate salts present in the composition are calcium cis-1,2-cyclohexanedicarboxylate monohydrate. A method for producing a polymer composition entails mixing the composition with a polyolefin polymer, melting the resulting admixture, and letting the admixture solidify to produce a polymer composition.

Abstract: A polymer composition comprises a polypropylene polymer and a salt of a branched alkyl phosphonic acid.

Abstract: An additive composition comprises an antioxidant and one or more calcium cis-1,2-cyclohexanedicarboxylate salts. 25 mol. % or more of the calcium cis-1,2-cyclohexanedicarboxylate salts present in the additive composition are calcium cis-1,2-cyclohexanedicarboxylate monohydrate. A method for producing a thermoplastic polymer composition entails mixing the additive composition with a thermoplastic polymer, melting the resulting admixture, and letting the admixture solidify to produce a polymer composition.

Abstract: A polymer composition comprises a polypropylene polymer and a salt of a branched alkyl phosphonic acid.

Abstract: An additive composition comprises an antioxidant and one or more calcium cis-1,2-cyclohexanedicarboxylate salts. 25 mol. % or more of the calcium cis-1,2-cyclohexanedicarboxylate salts present in the additive composition are calcium cis-1,2-cyclohexanedicarboxylate monohydrate. A method for producing a thermoplastic polymer composition entails mixing the additive composition with a thermoplastic polymer, melting the resulting admixture, and letting the admixture solidify to produce a polymer composition.

Abstract: An additive composition comprises phosphate ester anions conforming to a specified structure, aromatic carboxylate anions, optionally cycloaliphatic dicarboxylate anions, aluminum (III) cations, sodium cations, optionally calcium cations, optionally lithium cations, and optionally zinc (II) cations. The anions are present in the additive composition in specified molar percentages. The cations are also present in the additive composition in specified molar percentages.

Abstract: An additive composition comprises one or more calcium cis-1,2-cyclohexanedicarboxylate salts. 25 mol. % or more of the calcium cis-1,2-cyclohexanedicarboxylate salts present in the additive composition are calcium cis-1,2-cyclohexanedicarboxylate monohydrate. The additive composition has a gravimetric water content of about 20% or less. A method for producing a thermoplastic polymer composition entails mixing the additive composition with a thermoplastic polymer, melting the resulting admixture, and letting the admixture solidify to produce a polymer composition.

Abstract: An additive composition comprises one or more calcium cis-1,2-cyclohexanedicarboxylate salts. The calcium 1,2-cyclohexanedicarboxylate salts have a BET specific surface area of 20 m2/g or more. A method for producing a thermoplastic polymer composition entails mixing the additive composition with a thermoplastic polymer, melting the resulting admixture, and letting the admixture solidify to produce a polymer composition.

Abstract: An additive composition comprises one or more calcium cis-1,2-cyclohexanedicarboxylate salts. 25 mol. % or more of the calcium cis-1,2-cyclohexanedicarboxylate salts present in the additive composition are calcium cis-1,2-cyclohexanedicarboxylate monohydrate. The additive composition has a gravimetric water content of about 20% or less. A method for producing a thermoplastic polymer composition entails mixing the additive composition with a thermoplastic polymer, melting the resulting admixture, and letting the admixture solidify to produce a polymer composition.

Abstract: The present invention is directed to ophthalmic devices that are loaded with therapeutic agent. The devices provide prolonged release of the therapeutic agent to the eye. The ophthalmic devices are typically formed of an ophthalmic material that is particularly desirable for the loading of therapeutic agent and/or the therapeutic agent is typically particularly desirable for loading to the ophthalmic material.

Abstract: An additive composition comprises phosphate ester anions conforming to a specified structure, aromatic carboxylate anions, optionally cycloaliphatic dicarboxylate anions, aluminum (III) cations, sodium cations, optionally calcium cations, optionally lithium cations, and optionally zinc (II) cations. The anions are present in the additive composition in specified molar percentages. The cations are also present in the additive composition in specified molar percentages.

Abstract: The present invention is directed to ophthalmic devices that are loaded with therapeutic agent. The devices provide prolonged release of the therapeutic agent to the eye. The ophthalmic devices are typically formed of an ophthalmic material that is particularly desirable for the loading of therapeutic agent and/or the therapeutic agent is typically particularly desirable for loading to the ophthalmic material.

Abstract: The present invention is directed to ophthalmic devices that are loaded with therapeutic agent. The devices provide prolonged release of the therapeutic agent to the eye. The ophthalmic devices are typically formed of an ophthalmic material that is particularly desirable for the loading of therapeutic agent and/or the therapeutic agent is typically particularly desirable for loading to the ophthalmic material.

Abstract: A polyethylene article comprises crystalline polyethylene in an orthorhombic unit cell. The b-axes of the crystalline polyethylene are substantially aligned with the machine direction of the article. In particular, the Herman's index of the b-axes in the machine direction is greater than zero and greater than the Herman's indices of the b-axes in both the transverse and normal directions. The unique physical attributes exhibited by a polyethylene article having this new morphology are also described.

Abstract: The present invention is directed to ophthalmic devices that are loaded with therapeutic agent. The devices provide prolonged release of the therapeutic agent to the eye. The ophthalmic devices are typically formed of an ophthalmic material that is particularly desirable for the loading of therapeutic agent and/or the therapeutic agent is typically particularly desirable for loading to the ophthalmic material.

Abstract: The present invention is directed to ophthalmic devices that are loaded with therapeutic agent. The devices provide prolonged release of the therapeutic agent to the eye. The ophthalmic devices are typically formed of an ophthalmic material that is particularly desirable for the loading of therapeutic agent and/or the therapeutic agent is typically particularly desirable for loading to the ophthalmic material.